A

ADRX

ADRX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
ADRX Live QuoteReal-time
$12.79
$4.89(-27.66%)1M
Day Range$12.63 – $14.87
Open$14.03
Previous Close$14.16
Volume708.8K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$1.57B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-6.75
Price to Book2.5
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $12.79 (3%)
Low: $12.50High: $23.21
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$33.75-77.5% upside

Insider Buys

5

$87.75M

Insider Sales

0

$0

Total Volume

$87.75M

5 transactions

Net Activity

+$87.75M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
S
1

Sr One Capital Management, LLC

10%

1 buys0 sells

$27.20M total

G
2

George Simeon

Dir, 10%

1 buys0 sells

$27.20M total

G
3

Gordon Carl L

Dir, 10%

1 buys0 sells

$16.15M total

O
4

Orbimed Advisors LLC

Dir, 10%

1 buys0 sells

$16.15M total

C
5

Chimovits Erez

Dir

1 buys0 sells

$1.05M total

Trading History
ADRX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 28, 2026

1 months ago

Chimovits Erez

Dir

Director
Buy61.5K$17.00$1.05M

Sep 28, 2026

1 months ago

Gordon Carl L

Dir, 10%

Director
Buy950.0K$17.00$16.15M

Sep 28, 2026

1 months ago

Orbimed Advisors LLC

Dir, 10%

Director
Buy950.0K$17.00$16.15M

Sep 28, 2026

1 months ago

Sr One Capital Management, LLC

10%

10% Owner
Buy1.60M$17.00$27.20M

Sep 28, 2026

1 months ago

George Simeon

Dir, 10%

Director
Buy1.60M$17.00$27.20M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ADRX Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.5%
Total Industry Activity$16.52B

ADRX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ADRX

Over the last 90 days, corporate insiders at ADRX (ADRX) engaged in a total of 5 transactions reported via SEC Form 4 filings. Among these, 5 were open-market purchases and 0 were sales. The total volume of insider trading reached $87.75M.

The net insider activity for ADRX shows a net buying bias of $87.75M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Sr One Capital Management, LLC (10%), who traded 1.60M shares valued at $27.20M on Sep 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for ADRX (ADRX)
6 updates

symbol__ Stock Quote Price and Forecast

CNN59d ago

ADARx Pharmaceuticals, Inc. (ADRX) stock price, news, quote and history

Yahoo Finance Singapore2d ago

ADARx Pharmaceuticals,: ADRX Stock Price Quote & News

Robinhood56d ago

ADARx Pharmaceuticals (Nasdaq:ADRX) - Stock Analysis

Simply Wall St3d ago

ADRX Stock Price and Chart — NASDAQ:ADRX

TradingView74d ago

ADARx Pharmaceuticals (NASDAQ:ADRX) Stock: A Large Cash Reserve and Agazisiran Trials Frame the Quarter

kalkine.ca4d ago

FAQs About ADRX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ADRX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ADRX is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 5 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ADRX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.